For example, the FDA said about 20% of the bioreactor ... Sanofi (NYSE: SNY) acquired the Framingham facility when it bought Massachusetts-based Genzyme in a deal worth over $20 billion in 2011.

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

Maura Healey expanded Massachusetts' gun laws to include ... ghost guns often go hand-in-hand with those involved in drug distribution. Framingham police allege that is the case in last week's ...

23—THURSDAY, Jan. 23, 2025 (HealthDay News) — The U.S. Food and Drug Administration has warned the pharmaceutical ... ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On ...

THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ... at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning letter ...

The Food and Drug Administration has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts where the company makes ...

Vertex Pharmaceuticals Inc. hit a major milestone on Thursday when the U.S. Food and Drug Administration approved its ...

In today’s column we peruse a few of the most bloated pensions in the state hackerama. Every year, the state’s billion-dollar ...

Terry Hodge would have a tough time caring for the 150 or so elderly women at Bethany Health Care Center without the dozens of immigrant nursing assistants, housekeepers, dietary aides and other ...

HealthDay News — The U.S. Food and Drug Administration has warned the pharmaceutical ... active pharmaceutical ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15 ...